-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
BridgeBio Pharma, Inc. quarterly/annual Costs and Expenses history and growth rate from Q2 2020 to Q4 2024.
- BridgeBio Pharma, Inc. Costs and Expenses for the quarter ending December 31, 2024 was $232M, a 29.4% increase year-over-year.
- BridgeBio Pharma, Inc. Costs and Expenses for the twelve months ending December 31, 2024 was $815M, a 32.1% increase year-over-year.
- BridgeBio Pharma, Inc. annual Costs and Expenses for 2024 was $815M, a 32.1% increase from 2023.
- BridgeBio Pharma, Inc. annual Costs and Expenses for 2023 was $617M, a 4.55% increase from 2022.
- BridgeBio Pharma, Inc. annual Costs and Expenses for 2022 was $590M, a 8.74% decline from 2021.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)